Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus
Clinical trial NCT02250222 · COMPLETED
Trial details
- NCT number
- NCT02250222
- Sponsor
- Ligand Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.